Indivior Pharmaceuticals INDV Stock Today Drops 060 Key Support at 3471 20260518 Atlantic Am AAME Drops 222 Key Support at 209 20260518 Indias Nascent Semiconductor Sector Faces Chinas Stronghold in Mature Chips Gesher GSHRW Stock Steady at 022 Support at 021 20260519 Lanvin LANV Stock Up 968 Key Resistance at 178 20260520 Great Elm Capital Corp 850 Notes Due 2029 GECCI Edge Higher Near Par Value Root ROOT Stock Analysis Flat at 5659 Whats Next 20260521 Digi Realty DLR Q1 2026 Earnings Surprise EPS 047 Up Significant Analog Devices Sees Q3 Revenue Above Analyst Expectations Amid Semiconductor Recovery SP 500 Edges Higher as Tech Surge Offsets Energy Slide Brent Crudes 100 Price Target May Underestimate Tighter Oil Market Risks Wall Street Edges Higher as Consumer Rally Offsets Energy Drag RubioModi Meeting Signals USIndia Energy Cooperation Amid Iran Conflict Global Leaders Closely Monitor Potential TrumpXi Summit Amid Trade Tensions FCEL Q1 2026 Earnings EPS Surprises to the Upside Shares Dip Despite Narrowing Losses THRM Q1 2026 Earnings EPS Crushes Estimates with 625 Surprise Two Harbors TWOD Q1 2026 Earnings EPS Surges Past Estimates as Interest Rate Environment Supports Mortgage REIT Performance Seabridge Gold SA Q1 2024 Earnings DevelopmentStage Gold Company Posts Net Loss While Advancing KSM Project AvalonBay Communities Q1 2026 Earnings Massive EPS Beat Driven by Strong Operations Should Financially Comfortable Couples Hide Their Wealth From Friends A MarketWatch Column Explores TEVA Q1 2026 Earnings EPS Beats Estimates by Nearly 9 Stock Inches Higher CRGO Q4 2025 Earnings NarrowerthanExpected Loss Despite Macro Headwinds BingEx FLX Q1 2026 Earnings Net Loss Reported Amid Limited Disclosure GLPI Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Move FSTR Q1 2026 Earnings Stellar EPS Surprise of 16384 Drives Positive Market Reaction Ingredion INGR Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Strength NEUP Q1 2026 Earnings WiderThanExpected Loss Narrows Sharply as Clinical Pipeline Progress Drives Investor Optimism Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending